Penumbra (PEN)

• Market cap: $10.4B
• 1 day: 1.39%
• 5 days: -3.97%
• 1 month: -5.16%
• 3 months: 12.98%
• 6 months: 41.54%
• Year to date: 12.98%
• 1 year: 24.72%
• 5 years: 76.51%
• 10 years: 556.49%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

562% more call options, than puts

Call options by funds: $63.7M | Put options by funds: $9.62M

168% more first-time investments, than exits

New positions opened: 67 | Existing positions closed: 25

100% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 4 (+2) [Q4]

21% more capital invested

Capital invested by funds: $6.87B [Q3] → $8.3B (+$1.42B) [Q4]

11% more funds holding

Funds holding: 329 [Q3] → 366 (+37) [Q4]

0.02% less ownership

Funds ownership: 90.99% [Q3] → 90.97% (-0.02%) [Q4]

8% less repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 131

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $260 4% downside
• Avg. target: $313 15% upside
• High target: $340 25% upside

10 analyst ratings

• positive: 9 90%
• neutral: 1 10%
• negative: 0 0%

B of A Securities Travis Steed 17% 1-year accuracy 1 / 6 met price target	18% upside $320	Buy Initiated	14 Mar 2025
JP Morgan Robert Marcus 0% 1-year accuracy 0 / 1 met price target	5% upside $285	Overweight Maintained	19 Feb 2025
Truist Securities David Rescott 63% 1-year accuracy 10 / 16 met price target	20% upside $325	Buy Maintained	19 Feb 2025
RBC Capital Shagun Singh 55% 1-year accuracy 37 / 67 met price target	15% upside $313	Outperform Maintained	19 Feb 2025
Canaccord Genuity Jason Mills 56% 1-year accuracy 5 / 9 met price target	25% upside $340	Buy Maintained	19 Feb 2025